176k views
2 votes
a patient who is receiving nivolumab is experiencing grade 2 diarrhea. what dose of corticosteroids should the patient initally receive

User Crisp
by
8.6k points

1 Answer

1 vote

Answer:

It is important to understand that Nivolumab is a programmed cell death protein-1 (PD-1) blocking antibody used in cancer treatment. It can cause immune-related adverse events, such as diarrhea. The management of immune-related diarrhea depends on the grade of the diarrhea. The initial dose of corticosteroids for a patient who is experiencing grade 2 diarrhea due to nivolumab treatment is 1 to 2 mg/kg/day of prednisone or an equivalent corticosteroid.

This initial dose should be continued for 5 to 7 days, then tapered over the course of 2 to 4 weeks. If the diarrhea persists or worsens, the dose of corticosteroids may need to be increased or the patient may need to be hospitalized for intravenous corticosteroids and supportive care.

User Dignoe
by
7.8k points